I recall there was a discussion about how much ler
Post# of 148166
https://www.bioprocessonline.com/doc/the-peri...uster-0001
"Currently, CytoDyn is producing 2,000 liters per run, with immediate capacity to produce 12,000 liters per run. Upon approvals of leronlimab for its various indications, Pourhassan plans to leverage Samsung Biologics’ 180,000 liter-per-run capacity and Lonza’s 150,000 liter capacity to facilitate the product’s commercial scale-up."
That's a lot of liters.
Anyone know how many liters of lero CYDY has in their commercial-grade supply? Again according to the article [my edit]:
"He [Pourhassan] also acknowledges that dipping into the company’s $50 million stockpile of commercial-grade product could sustain its clinical trial needs through the end of 2020 if necessary."
I'm assuming the valuation is based on COGS. Just wondering what the COGS how much revenue can be made off of it.